The chromatin immunoprecipitation assay is a powerful and versatile technique used for probing protein-DNA interactions within the natural chromatin context of the cell. This assay can be used to identify multiple proteins associated with a specific region of the genome, or the opposite, to identify the many regions of the genome bound by a particular protein. It can be used to determine the specific order of recruitment of various proteins to a gene promoter or to "measure" the relative amount of a particular histone modification across an entire gene locus. In addition to histone proteins, the ChIP assay can be used to analyze binding of transcription factors and co-factors, DNA replication factors and DNA repair proteins. When performing the ChIP assay, cells or tissues are first fixed with formaldehyde, a reversible protein-DNA cross-linking agent that "preserves" the protein-DNA interactions occurring in the cell. Cells are lysed and chromatin is harvested and fragmented using either sonication or enzymatic digestion. The chromatin is then immunoprecipitated with antibodies specific to a particular protein or histone modification. Any DNA sequences that are associated with the protein or histone modification of interest will co-precipitate as part of the cross-linked chromatin complex and the relative amount of that DNA sequence will be enriched by the immunoselection process. After immunoprecipitation, the protein-DNA cross-links are reversed and the DNA is purified. Standard PCR or Quantitative Real-Time PCR can be used to measure the amount of enrichment of a particular DNA sequence by a protein-specific immunoprecipitation. Alternatively, the ChIP assay can be combined with genomic tiling micro-array techniques, high throughput sequencing, or cloning strategies, all of which allow for genome-wide analysis of protein-DNA interactions and histone modifications.
[1] Orlando, V. (2000) Trends Biochem Sci 25, 99-104.
[2] Liu, Q. et al. (2000) Genes Dev 14, 1448-59.
[3] Kuo, M.H. and Allis, C.D. (1999) Methods 19, 425-33.
[4] Zhao, H. and Piwnica-Worms, H. (2001) Mol Cell Biol 21, 4129-39.
[5] Agalioti, T. et al. (2000) Cell 103, 667-78.
[6] Jiang, K. et al. (2003) J Biol Chem 278, 25207-17.
[7] Soutoglou, E. and Talianidis, I. (2002) Science 295, 1901-4.
[8] Martin, S.A. and Ouchi, T. (2008) Mol Cancer Ther 7, 2509-16.
[9] Mikkelsen, T.S. et al. (2007) Nature 448, 553-60.
[10] Chen, M.S. et al. (2003) Mol Cell Biol 23, 7488-97.